Agenus (AGEN) News Today

$12.95
-0.12 (-0.92%)
(As of 04:00 PM ET)
SourceHeadline
MarketBeat logoAgenus (AGEN) to Release Earnings on Tuesday
americanbankingnews.com - May 5 at 5:36 AM
msn.com logoWhat to Make of Agenus Stock (NASDAQ:AGEN) Post Reverse Stock Split
msn.com - May 1 at 9:18 PM
finance.yahoo.com logoAgenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
finance.yahoo.com - May 1 at 9:51 AM
seekingalpha.com logoTime Is Running Out For Agenus To Raise Cash
seekingalpha.com - April 30 at 8:26 PM
marketbeat.com logoAgenus (AGEN) Scheduled to Post Earnings on Tuesday
marketbeat.com - April 30 at 12:16 PM
msn.com logoCompare with S&P 500 Growth Index SGD Total Return (500GST)
msn.com - April 29 at 10:10 AM
fool.com logoUp 40%: Is This Red-Hot Growth Stock Still a Buy?
fool.com - April 28 at 8:46 AM
fool.com logoUp 40%: Is This Red-Hot Growth Stock Still a Buy?
fool.com - April 28 at 8:30 AM
finance.yahoo.com logoAgenus Inc. (AGEN)
finance.yahoo.com - April 27 at 3:14 AM
MarketBeat logoAgenus Inc. (NASDAQ:AGEN) Sees Significant Decrease in Short Interest
americanbankingnews.com - April 26 at 1:32 AM
marketbeat.com logoAgenus Inc. (NASDAQ:AGEN) Short Interest Update
marketbeat.com - April 25 at 7:06 PM
finance.yahoo.com logoBotensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
finance.yahoo.com - April 24 at 10:20 AM
benzinga.com logoTop 2 Health Care Stocks Which Could Rescue Your Portfolio This Month - Agenus (NASDAQ:AGEN), MultiPlan (NYSE:MPLN)
benzinga.com - April 23 at 8:36 AM
businesswire.com logoAgenus to Provide First Quarter 2024 Financial Report and Corporate Update
businesswire.com - April 23 at 7:30 AM
nasdaq.com logoCommit To Purchase Agenus At $1, Earn 2607.1% Annualized Using Options
nasdaq.com - April 13 at 10:12 PM
markets.businessinsider.com logoSmall-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
markets.businessinsider.com - April 12 at 5:46 PM
nasdaq.com logoAgenus Updates Phase 1 Data Of BOT/BAL Therapy In MSS Metastatic Colorectal Cancer
nasdaq.com - April 12 at 12:45 PM
markets.businessinsider.com logoAgenus Stock Falls After Reporting Updated Phase 1 Data On Colorectal Cancer Therapy
markets.businessinsider.com - April 12 at 12:45 PM
msn.com logoAgenus reports updated Phase 1 data on colorectal cancer therapy
msn.com - April 12 at 12:45 PM
marketbeat.com logoAgenus (NASDAQ:AGEN) Reaches New 12-Month Low at $8.10
marketbeat.com - April 12 at 10:53 AM
finance.yahoo.com logoAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
finance.yahoo.com - April 12 at 7:45 AM
businesswire.com logoAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
businesswire.com - April 12 at 7:30 AM
marketbeat.com logo
marketbeat.com - April 12 at 6:04 AM
marketbeat.com logoAgenus (NASDAQ:AGEN) Shares Scheduled to Reverse Split on Friday, April 12th
marketbeat.com - April 8 at 7:31 PM
marketwatch.com logoMiNK Therapeutics' MiNK-215 Data Show Potential Treatment for Liver Metastases
marketwatch.com - April 8 at 2:35 PM
fool.com logoDown 75%. Is Agenus Stock a Buy on the Dip?
fool.com - April 8 at 3:34 AM
investing.com logoAgenus announces reverse stock split to meet Nasdaq requirements
investing.com - April 7 at 9:48 AM
businesswire.com logoAgenus Announces Reverse Stock Split of Common Stock
businesswire.com - April 5 at 4:30 PM
marketbeat.com logoAssenagon Asset Management S.A. Acquires 2,232,064 Shares of Agenus Inc. (NASDAQ:AGEN)
marketbeat.com - April 5 at 4:29 AM
fool.com logo2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
fool.com - April 3 at 4:19 AM
investorplace.com logo3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
investorplace.com - March 24 at 4:05 PM
ca.finance.yahoo.com logoAGEN Aug 2024 2.000 put
ca.finance.yahoo.com - March 20 at 4:39 AM
marketbeat.com logoAgenus (NASDAQ:AGEN) Rating Reiterated by HC Wainwright
marketbeat.com - March 18 at 3:10 PM
marketbeat.com logoAgenus (NASDAQ:AGEN) Price Target Cut to $5.00 by Analysts at B. Riley
marketbeat.com - March 18 at 3:10 PM
finance.yahoo.com logoUS$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results
finance.yahoo.com - March 17 at 10:17 AM
markets.businessinsider.com logoBuy Rating Affirmed for Agenus Amidst Promising Cancer Immunotherapy Developments and Strategic Financial Moves
markets.businessinsider.com - March 16 at 1:18 AM
benzinga.com logoEarnings Preview For Agenus
benzinga.com - March 15 at 8:17 PM
finance.yahoo.com logoAgenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 15 at 3:17 PM
finance.yahoo.com logoAnalysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramatically
finance.yahoo.com - March 15 at 10:16 AM
ca.finance.yahoo.com logoAGEN Mar 2024 2.000 put
ca.finance.yahoo.com - March 15 at 12:15 AM
markets.businessinsider.com logoAgenus Poised for Growth: Anticipated BLA Filing and Promising Clinical Data Underpin Buy Rating
markets.businessinsider.com - March 14 at 7:15 PM
finance.yahoo.com logoDogecoin spikes after Musk hints at Tesla payment option
finance.yahoo.com - March 14 at 2:15 PM
fool.com logoAgenus (AGEN) Q4 2023 Earnings Call Transcript
fool.com - March 14 at 2:15 PM
sfgate.com logoAgenus: Q4 Earnings Snapshot
sfgate.com - March 14 at 9:14 AM
gurufocus.com logoAgenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipeline
gurufocus.com - March 14 at 8:03 AM
businesswire.com logoAgenus Reports Fourth Quarter and Full Year 2023 Results
businesswire.com - March 14 at 7:30 AM
markets.businessinsider.com logoHere's what to expect from Agenus's earnings report
markets.businessinsider.com - March 13 at 2:40 PM
marketbeat.com logoAgenus (NASDAQ:AGEN) Upgraded at StockNews.com
marketbeat.com - March 8 at 11:17 PM
finance.yahoo.com logoAgenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
finance.yahoo.com - March 6 at 7:02 PM
marketbeat.com logoAgenus Inc. (NASDAQ:AGEN) Shares Sold by Oracle Investment Management Inc.
marketbeat.com - March 1 at 11:48 AM
Get Agenus News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter.

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

AGEN Media Mentions By Week

AGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGEN
News Sentiment

0.10

0.40

Average
Medical
News Sentiment

AGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGEN Articles
This Week

5

2

AGEN Articles
Average Week

Get Agenus News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AGEN) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners